Neuromuscular manifestations of critical illness

Critical illness, more precisely defined as the systemic inflammatory response syndrome (SIRS), occurs in 20%–50% of patients who have been on mechanical ventilation for more than 1 week in an intensive care unit. Critical illness polyneuropathy (CIP) and myopathy (CIM), singly or in combination, occur commonly in these patients and present as limb weakness and difficulty in weaning from the ventilator. Critical illness myopathy can be subdivided into thick‐filament (myosin) loss, cachectic myopathy, acute rhabdomyolysis, and acute necrotizing myopathy of intensive care. SIRS is the predominant underlying factor in CIP and is likely a factor in CIM even though the effects of neuromuscular blocking agents and steroids predominate in CIM. Identification and characterization of the polyneuropathy and myopathy depend upon neurological examination, electrophysiological studies, measurement of serum creatine kinase, and, if features suggest a myopathy, muscle biopsy. The information is valuable in deciding treatment and prognosis. Muscle Nerve, 2005

[1]  T. Landis,et al.  [Diseases of the peripheral nervous system]. , 2007, Revue medicale suisse.

[2]  J. Raphaël,et al.  [Guillain-Barré syndrome]. , 2005, La Revue du praticien.

[3]  F. Leijten,et al.  Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator , 1996, Intensive Care Medicine.

[4]  J. Willeit,et al.  Polyneuropathies in critically ill patients: A prospective evaluation , 1996, Intensive Care Medicine.

[5]  C. Bolton,et al.  Neuromuscular disorders associated with failure to wean from the ventilator , 1995, Intensive Care Medicine.

[6]  Professor F. Lemaire Difficult weaning , 2005, Intensive Care Medicine.

[7]  M. Honavar,et al.  Preliminary observations on the neuromuscular abnormalities in patients with organ failure and sepsis , 2005, Intensive Care Medicine.

[8]  Margaret M Parker,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[9]  E. Hoffman,et al.  Constitutive activation of MAPK cascade in acute quadriplegic myopathy , 2004, Annals of neurology.

[10]  M. Aubier,et al.  Respiratory muscle fatigue , 1989, Intensive Care Medicine.

[11]  Dieter Mesotten,et al.  Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  P. Ward,et al.  The enigma of sepsis. , 2003, The Journal of clinical investigation.

[13]  Y. Almog,et al.  The coagulopathy of sepsis: pathophysiology and management. , 2003, The Israel Medical Association journal : IMAJ.

[14]  R. Kandler,et al.  Focal neuropathy in children with critical illness. , 2003, Neuropediatrics.

[15]  G. Young,et al.  Progress in Clinical Neurosciences: Sepsis-Associated Encephalopathy: Evolving Concepts , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  Peter A. Ward,et al.  Novel strategies for the treatment of sepsis , 2003, Nature Medicine.

[17]  N. Latronico,et al.  Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders , 2003, Acta Neuropathologica.

[18]  V. P. Misra,et al.  Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness* , 2003, Critical care medicine.

[19]  Isabelle Durand-Zaleski,et al.  Paresis acquired in the intensive care unit: a prospective multicenter study. , 2002, JAMA.

[20]  M. Rich,et al.  Critical illness myopathy and polyneuropathy , 2002, Current neurology and neuroscience reports.

[21]  H. Sander,et al.  Quadriplegic areflexic ICU illness: Selective thick filament loss and normal nerve histology , 2002, Muscle & nerve.

[22]  van Mook Wn,et al.  Critical illness polyneuropathy , 2002, Current opinion in critical care.

[23]  John Land,et al.  Association between mitochondrial dysfunction and severity and outcome of septic shock , 2002, The Lancet.

[24]  M. Rich,et al.  ECG Changes during Septic Shock , 2002, Cardiology.

[25]  M. Magistris [Critical illness neuropathies]. , 2002, Revue neurologique.

[26]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[27]  M. D. Letter Critical illness polyneuropathy and myopathy; a neuromuscular disorder encountered in the intensive care unit , 2001 .

[28]  L. Visser,et al.  Risk factors for the development of polyneuropathy and myopathy in critically ill patients , 2001, Critical care medicine.

[29]  J. Katz,et al.  Malnutrition‐induced myopathy following Roux‐en‐Y gastric bypass , 2001, Muscle & nerve.

[30]  E. Hund Neurological complications of sepsis: critical illness polyneuropathy and myopathy , 2001, Journal of Neurology.

[31]  Ò. Miró,et al.  Acute quadriplegic myopathy with loss of thick (myosin) filaments following heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[32]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[33]  W. Trojaborg,et al.  Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy – a reappraisal , 2001, Clinical Neurophysiology.

[34]  K. Kaiboriboon,et al.  Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy? , 2001, Neuromuscular Disorders.

[35]  C. Esmon,et al.  Dysfunction of endothelial protein C activation in severe meningococcal sepsis. , 2001, The New England journal of medicine.

[36]  J. Garnacho-Montero,et al.  Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients , 2001, Intensive Care Medicine.

[37]  T. Mozaffar Critical illness myopathy , 2001, Muscle & nerve.

[38]  M. Pinter,et al.  Sodium channel inactivation in an animal model of acute quadriplegic myopathy , 2001, Annals of neurology.

[39]  K. Druschky,et al.  Critical illness polyneuropathy: clinical findings and cell culture assay of neurotoxicity assessed by a prospective study , 2001, Intensive Care Medicine.

[40]  C. Vedeler,et al.  [Neuromuscular complications of sepsis]. , 2001, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[41]  A. Vincent,et al.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies , 2001, Nature Medicine.

[42]  R. Roine,et al.  Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis , 2000, Intensive Care Medicine.

[43]  J. Kros,et al.  Critical illness polyneuropathy and myopathy (CIPNM): evidence for local immune activation by cytokine-expression in the muscle tissue , 2000, Journal of Neuroimmunology.

[44]  Paterson Rl,et al.  Sepsis and the systemic inflammatory response syndrome. , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[45]  P. Joseph,et al.  Critical Illness Polyneuropathy , 2000, European Neurology.

[46]  L. Larsson,et al.  Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels , 2000, Critical care medicine.

[47]  A. Beelen,et al.  Critical illness polyneuropathy: a summary of the literature on rehabilitation outcome , 2000, Disability and rehabilitation.

[48]  U. Zifko Long‐term outcome of critical illness polyneuropathy , 2000, Muscle & nerve. Supplement.

[49]  P. Joseph,et al.  Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. , 2000, European neurology.

[50]  M. Rich,et al.  Altered Gene Expression in Steroid-Treated Denervated Muscle , 1999, Neurobiology of Disease.

[51]  E. Hund Myopathy in critically ill patients. , 1999, Critical care medicine.

[52]  A. Höke,et al.  Acute Quadriplegic Myopathy Unrelated to Steroids or Paralyzing Agents: Quantitative EMG Studies , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[53]  H. Strassburg,et al.  Critical illness neuropathy in pediatric intensive care patients. , 1999, Pediatric neurology.

[54]  H. Hartmann,et al.  Glycosylation Influences Voltage-Dependent Gating of Cardiac and Skeletal Muscle Sodium Channels , 1999, The Journal of Membrane Biology.

[55]  C. Bolton Critical illness polyneuropathy: A useful concept , 1999 .

[56]  S. Chokroverty,et al.  Diaphragmatic denervation in intensive care unit patients. , 1999, Electromyography and clinical neurophysiology.

[57]  S. Ash,et al.  Systemic inflammatory response syndrome treatment by powdered sorbent pheresis: the BioLogic-Detoxification Plasma Filtration System. , 1998, ASAIO journal.

[58]  C. Bolton,et al.  Clinical and electrophysiological findings in critical illness polyneuropathy , 1998, Journal of the Neurological Sciences.

[59]  Declan M. McLoughlin,et al.  Structural and functional changes in skeletal muscle in anorexia nervosa , 1998, Acta Neuropathologica.

[60]  M. Giuliani,et al.  Causes of neuromuscular weakness in the intensive care unit: A study of ninety‐two patients , 1998, Muscle & nerve.

[61]  C. Bolton,et al.  Diagnostic difficulties in myasthenia gravis , 1998, Muscle & nerve.

[62]  M. Pinter,et al.  Loss of electrical excitability in an animal model of acute quadriplegic myopathy , 1998, Annals of neurology.

[63]  U. Zifko Electrophysiological Respiratory Studies in the Critical Care Unit , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[64]  F. Grand'Maison Methods of Testing Neuromuscular Transmission in the Intensive Care Unit , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[65]  A. V. Van Cott,et al.  Acute myopathy after liver transplantation , 1998, Neurology.

[66]  P. L. Marino,,et al.  Possible role of dietary lipids in critical illness polyneuropathy , 1998, Intensive Care Medicine.

[67]  J. Brucher,et al.  Acute corticosteroid myopathy in intensive care patients , 1997, Muscle & nerve.

[68]  Bolton Cf,et al.  Critical illness polyneuropathy due to parenteral nutrition. , 1997 .

[69]  E. Waldhausen,et al.  Critical illness polyneuropathy due to parenteral nutrition. , 1997, Intensive Care Medicine.

[70]  M. Rich,et al.  Direct muscle stimulation in acute quadriplegic myopathy , 1997, Muscle & nerve.

[71]  A. Straube,et al.  Single‐fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical‐illness polyneuropathy: Evidence for a lesion of terminal motor axons , 1997, Muscle & nerve.

[72]  C. Bolton,et al.  Motor neuron disease presenting as acute respiratory failure: Electrophysiological studies , 1997, Muscle & nerve.

[73]  A. Engel,et al.  Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain‐mediated proteolysis , 1997, Muscle & nerve.

[74]  Bolton Cf,et al.  The neurological consultation and neurological syndromes in the intensive care unit. , 1996 .

[75]  C. Bolton,et al.  Lambert‐Eaton myasthenic syndrome presenting with severe respiratory failure , 1996, Muscle & nerve.

[76]  A. V. Van Cott,et al.  Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects , 1996, Annals of neurology.

[77]  C. Bolton,et al.  Neuromuscular disorders in critical illness. , 1996, Baillière's Clinical Neurology.

[78]  C. Bolton,et al.  Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. , 1996, Critical care medicine.

[79]  D. Krieger,et al.  Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. , 1996 .

[80]  D. Recupero,et al.  Critical illness myopathy and neuropathy , 1996, The Lancet.

[81]  X. Dennett,et al.  Critical care myopathy: An electrophysiological and histological study , 1996, Muscle & nerve.

[82]  W. Scheld,et al.  Infectious etiologies of rhabdomyolysis: three case reports and review. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  M. Rich,et al.  Muscle is electrically inexcitable in acute quadriplegic myopathy , 1996, Neurology.

[84]  C. Bolton,et al.  Respiratory electrophysiological studies in Guillain-Barré syndrome. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[85]  R. Zager,et al.  Rhabdomyolysis and myohemoglobinuric acute renal failure. , 1996, Kidney international.

[86]  C. Bolton,et al.  The neurological consultation and neurological syndromes in the intensive care unit. , 1996, Bailliere's clinical neurology.

[87]  F. Leijten,et al.  The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. , 1996, JAMA.

[88]  S. Bendahhou,et al.  Serine-1321-independent regulation of the mu 1 adult skeletal muscle Na+ channel by protein kinase C. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[89]  C. Bolton The changing concepts of Guillain-Barré syndrome. , 1995, The New England journal of medicine.

[90]  J. Mendell,et al.  Critical Illness Polyneuropathy in a 2-Year-Old Girl With Hemorrhagic Shock Encephalopathy Syndrome , 1995, Journal of child neurology.

[91]  C. Bolton,et al.  Topical Review: Neuromuscular Complications of Sepsis in Children , 1995 .

[92]  J. Slopis,et al.  Critical Illness Polyneuropathy in Adolescence , 1995, Journal of child neurology.

[93]  R. Bone Sepsis and the systemic inflammatory response syndrome (SIRS) , 1995 .

[94]  C. M. Wiles,et al.  Critical illness poly-neuropathy following severe hyperpyrexia. , 1995, QJM : monthly journal of the Association of Physicians.

[95]  E. Wijdicks Neurology of critical illness , 1995 .

[96]  J. Gooch Prolonged paralysis after neuromuscular blockade. , 1995, Journal of toxicology. Clinical toxicology.

[97]  C. Bolton,et al.  Neuromuscular complications of sepsis in children. , 1995, Journal of child neurology.

[98]  E. Wijdicks,et al.  Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. , 1994, Muscle & nerve.

[99]  J. Dhainaut,et al.  Platelet‐activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double‐blind, placebo‐controlled, multicenter clinical trial , 1994 .

[100]  K. Reinhart,et al.  Influence of N‐acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double‐blind study , 1994, Critical care medicine.

[101]  E. Wijdicks,et al.  The clinical spectrum of critical illness polyneuropathy. , 1994, Mayo Clinic proceedings.

[102]  R. Horn,et al.  Voltage-dependent regulation of modal gating in the rat SkM1 sodium channel expressed in Xenopus oocytes , 1994, The Journal of general physiology.

[103]  A. J. Block The First Year is Behind Me , 1994 .

[104]  C. Bolton Muscle weakness and difficulty in weaning from the ventilator in the critical care unit. , 1994, Chest.

[105]  S. Lowry Sepsis and its complications: clinical definitions and therapeutic prospects. , 1994, Critical Care Medicine.

[106]  M. Magistris,et al.  Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination. , 1994, Chest.

[107]  C. Jackson,et al.  Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids , 1994, Muscle & nerve.

[108]  D. Heney,et al.  Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study , 1994, Critical care medicine.

[109]  D. Ramsay,et al.  Acute necrotizing myopathy of intensive care: Electrophysiological studies , 1994, Muscle & nerve.

[110]  A. Pestronk,et al.  Rapidly evolving myopathy with myosin‐deficient muscle fibers , 1994, Annals of neurology.

[111]  F. Leijten,et al.  Critical illness polyneuropathy a review of the literature, definition and pathophysiology , 1994, Clinical Neurology and Neurosurgery.

[112]  D. Lange,et al.  Neuromuscular diseases , 2000, Clinical Neurophysiology.

[113]  J. Solomkin Very large-scale, randomized, clinical trials in sepsis and septic shock. , 1994, Critical care medicine.

[114]  G. Durand,et al.  [Neuropathies of septic syndrome with multiple organ failure in burnt patients: 2 cases with review of the literature]. , 1994, Revue neurologique.

[115]  J. Dhainaut,et al.  Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. , 1994, Critical care medicine.

[116]  M. Matthay,et al.  Prevalence and severity of neurologic dysfunction in critically ill patients. Influence on need for continued mechanical ventilation. , 1993, Chest.

[117]  C. Bolton AAEM minimonograph #40: Clinical neurophysiology of the respiratory system , 1993, Muscle & nerve.

[118]  J. Mendell,et al.  Polyneuropathy complicating bone marrow and solid organ transplantation , 1993, Neurology.

[119]  S. Ludwin,et al.  A Syndrome of Acute Severe Muscle Necrosis in Intensive Care Unit Patients , 1993, Journal of neuropathology and experimental neurology.

[120]  W. Peters,et al.  Neuropathy in burn patients. , 1993, Brain : a journal of neurology.

[121]  A. Ropper,et al.  Acute respiratory failure neuropathy: A variant of critical illness polyneuropathy , 1993, Critical care medicine.

[122]  C. Bolton,et al.  The neurological complications of sepsis , 1993, Annals of neurology.

[123]  D. Lacomis,et al.  Acute myopathy and neuropathy in status asthmaticus: Case report and literature review , 1993, Muscle & nerve.

[124]  J. Chevrolet,et al.  Neuromyopathies secondaires en réanimation , 1993 .

[125]  R. Massa,et al.  Loss and renewal of thick myofilaments in glucocorticoid‐treated rat soleus after denervation and reinnervation , 1992, Muscle & nerve.

[126]  Y. Kupfer,et al.  Prolonged Weakness after Long-Term Infusion of Vecuronium Bromide , 1992, Annals of Internal Medicine.

[127]  R D Miller,et al.  Persistent paralysis in critically ill patients after long-term administration of vecuronium. , 1992, The New England journal of medicine.

[128]  M. Weinmann,et al.  Myopathy in severe asthma. , 1992, The American review of respiratory disease.

[129]  J. E. Carceller American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[130]  G. Awerbuch,et al.  Neuromuscular causes of prolonged ventilator dependency , 1992, Muscle & nerve.

[131]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[132]  Y. Archibald,et al.  The Electroencephalogram in Sepsis‐Associated Encephalopathy , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[133]  R. Schellens,et al.  Critical illness polyneuromyopathy after artificial respiration , 1991, Clinical Neurology and Neurosurgery.

[134]  R. Bone,et al.  Sepsis syndrome. New insights into its pathogenesis and treatment. , 1991, Infectious disease clinics of North America.

[135]  S. Subramony,et al.  Myopathy and prolonged neuromuscular blockade after lung transplant , 1991, Critical care medicine.

[136]  P. Souney,et al.  Pancuronium‐induced prolonged neuromuscular blockade , 1991, Critical care medicine.

[137]  S. Carpenter,et al.  Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment , 1991, Muscle & nerve.

[138]  M. Glauser,et al.  Septic shock: pathogenesis , 1991, The Lancet.

[139]  Prolonged paralysis after treatment with neuromuscular junction blocking agents , 1991, Critical care medicine.

[140]  R. Griffiths,et al.  Necrotizing myopathy in critically‐ill patients , 1991, The Journal of pathology.

[141]  D. Reid,et al.  Complete ophthalmoplegia as a complication of acute corticosteroid‐ and pancuronium‐associated myopathy , 1991, Neurology.

[142]  W. Sibbald,et al.  Peripheral nerve function in sepsis and multiple organ failure. , 1991, Chest.

[143]  Y. Archibald,et al.  The encephalopathy associated with septic illness. , 1990, Clinical and investigative medicine. Medecine clinique et experimentale.

[144]  B. Partridge,et al.  Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit. , 1990, Critical care medicine.

[145]  E. Zomer,et al.  [Critical illness polyneuropathy]. , 1990, Nederlands tijdschrift voor geneeskunde.

[146]  R. Zatorre,et al.  Neurological sequelae of domoic acid intoxication. , 1990, Canada diseases weekly report = Rapport hebdomadaire des maladies au Canada.

[147]  A. Groeneveld,et al.  Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. , 1990, Critical care medicine.

[148]  NHLBI Workshop summary. Respiratory muscle fatigue. Report of the Respiratory Muscle Fatigue Workshop Group. , 1990, The American review of respiratory disease.

[149]  T. Kosatsky,et al.  Neurologic sequelae after ingestion of mussels contaminated with domoic acid. , 1990, The New England journal of medicine.

[150]  N. Braun,et al.  Diaphragmatic dysfunction after open heart surgery: treatment with a rocking bed. , 1989, Annals of internal medicine.

[151]  K. Tracey,et al.  Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. , 1989, The American journal of physiology.

[152]  Marcus J. Schultz,et al.  The Society of Critical Care Medicine , 1989 .

[153]  J. Wokke,et al.  Histological investigations of muscle atrophy and end plates in two critically ill patients with generalized weakness , 1988, Journal of the Neurological Sciences.

[154]  C. Bolton,et al.  Metabolic changes in human muscle denervation: Topical 31P NMR spectroscopy studies , 1988, Magnetic resonance in medicine.

[155]  C. Bolton,et al.  Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. , 1987, Brain : a journal of neurology.

[156]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[157]  S. Carpenter,et al.  Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers , 1987, Muscle & nerve.

[158]  C. Bolton Electrophysiologic studies of critically ill patients , 1987, Muscle & nerve.

[159]  C. Bolton Weaning failure due to acute neuromuscular disease. , 1987, Critical care medicine.

[160]  J. Mazaux,et al.  [Polyneuropathies during prolonged stays in resuscitation]. , 1987, Revue neurologique.

[161]  W. Brown,et al.  An acute axonal form of Guillain-Barré polyneuropathy. , 1986, Brain : a journal of neurology.

[162]  H. Milner-Brown,et al.  Muscle membrane excitation and impulse propagation velocity are reduced during muscle fatigue , 1986, Muscle & nerve.

[163]  W. Sibbald,et al.  Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[164]  J. Zimmerman,et al.  Weaning failure due to acute neuromuscular disease. , 1986, Critical care medicine.

[165]  A. Rossier Letter to the Editor , 1986, Paraplegia.

[166]  H. Laak,et al.  Neuromuscular complications in patients given pavulon/sr (pancuronium bromide) during artificial ventilation , 1985, Clinical Neurology and Neurosurgery.

[167]  G. Young,et al.  The Encephalopathy of Sepsis , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[168]  J. Vestrup,et al.  Myositis and rhabdomyolysis due to Staphylococcus aureus septicemia. , 1984, The Journal of infectious diseases.

[169]  W. Sibbald,et al.  Polyneuropathy in critically ill patients. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[170]  J. Couturier,et al.  Polynévrites compliquant des séjours prolongés en réanimation. A propos de 11 cas d'étiologie encore inconnue , 1984 .

[171]  C. Marsden,et al.  Postanoxic symptomatic oscillatory myoclonus , 1983, Neurology.

[172]  P A Pappone,et al.  Voltage‐clamp experiments in normal and denervated mammalian skeletal muscle fibres. , 1980, The Journal of physiology.

[173]  A. Wernig,et al.  Sprouting and regression of the nerve at the frog neuromuscular junction in normal conditions and after prolonged paralysis with curare , 1980, Journal of neurocytology.

[174]  S. Shafiq,et al.  Acute myopathy with selective lysis of myosin filaments , 1979, Neurology.

[175]  D. Cocchi,et al.  Ultrastructure of somatotrophs of rats with median eminence lesions: studies in basal conditions and after thyrotropin-releasing hormone stimulation. , 1979, Neuroendocrinology.

[176]  I. MacFarlane,et al.  SEVERE MYOPATHY AFTER STATUS ASTHMATICUS , 1977, The Lancet.

[177]  A. Bischoff,et al.  [Gentamicin neurotoxicity (polyneuropathy--encephalopathy)]. , 1977, Schweizerische medizinische Wochenschrift.

[178]  P. Helm,et al.  Peripheral neurological problems in the acute burn patient , 1977 .

[179]  A. Eisen,et al.  Experimental core-like lesions and nemaline rods. A correlative morphological and physiological study. , 1972, Archives of neurology.

[180]  I. Feller,et al.  Peripheral polyneuropathy among patients with burns. , 1971, Archives of physical medicine and rehabilitation.

[181]  R. H. Jebsen,et al.  POLYNEUROPATHY IN CHRONIC RENAL INSUFFICIENCY. , 1965, JAMA.

[182]  I. Antonov,et al.  [On diseases of the peripheral nervous system]. , 1962, Zdravookhranenie Belorussii.

[183]  Mertens Hg [Disseminated neuropathy following coma. On the differentation of so-called toxic polyneuropathy]. , 1961 .

[184]  H. Mertens [Disseminated neuropathy following coma. On the differentation of so-called toxic polyneuropathy]. , 1961, Der Nervenarzt.

[185]  F. Erbsloh [Polyneuritic pathological conditions in internal medicine]. , 1955, Munchener medizinische Wochenschrift.

[186]  J. Wilkinson,et al.  The Principles and Practice of Medicine , 1886, Edinburgh Medical Journal.